Category Archives: Warning Letters

OPDP Warning and Untitled Letters – A Separation; a New Letter from OPDP

This is sort of a two-for posting. First we will look at a change in how FDA is reporting regulatory actions by OPDP on the FDA website, and second we will cover the most recent such action. OPDP Warning Letter … Continue reading

Posted in Warning Letters | Tagged , | Comments Off on OPDP Warning and Untitled Letters – A Separation; a New Letter from OPDP

2020 OPDP Enforcement

Last month we looked at a review of FDA press releases for last year and as one might have expected, there was an enormous spike in communications as a result of the COVID-19 pandemic. Looking now to a review of … Continue reading

Posted in Warning Letters | Comments Off on 2020 OPDP Enforcement

Time for FDA’s OPDP to Fill the Gaps on Digital and Social Media

At mid-year, it has been a custom here at Eye on FDA to look back at a few categories of activity by FDA at the first half of the year and discern what it tells us about future directions. This … Continue reading

Posted in Warning Letters | Tagged | Comments Off on Time for FDA’s OPDP to Fill the Gaps on Digital and Social Media

OPDP Issues First Letter of the Year

Hey! 2009 called. They want their Warning Letter back! Last week FDA’s Office of Prescription Drug Promotion (OPDP) posted the first letter issued for 2020 that was sent in February for the most common violation of all – related to … Continue reading

Posted in Warning Letters | Comments Off on OPDP Issues First Letter of the Year

An Overview of FDA OPDP Enforcement for 2019

It is time to look back at enforcement for the 2019 year. It is still possible that FDA could post another letter, as there is a lag time between the time a letter is sent and the time it is … Continue reading

Posted in Warning Letters | Tagged , , | Comments Off on An Overview of FDA OPDP Enforcement for 2019